Hydroxyurea: FDA-Approved Antimetabolite for CML & Sickle Cell
Last Updated: July 2026 Published by: Saif Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Nusrat Jahan, MBBS, MD (Medical Oncology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory product documentation from SFDA and DGDA (Directorate General of Drug
Hydroxyurea: FDA-Approved Antimetabolite for CML & Sickle Cell Read More »
